KBR (KBR)
(Delayed Data from NYSE)
$63.08 USD
+0.10 (0.16%)
Updated Jun 7, 2024 04:00 PM ET
After-Market: $63.09 +0.01 (0.02%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth B Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$63.08 USD
+0.10 (0.16%)
Updated Jun 7, 2024 04:00 PM ET
After-Market: $63.09 +0.01 (0.02%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth B Momentum B VGM
Zacks News
KBR Growth Prospects Bright on Multiple Global Contracts
by Zacks Equity Research
Premium engineering, procurement and construction company, KBR, Inc. (KBR), is on a roll, securing a bunch of contracts across the globe.
KBR Wins Twin Global Contracts from BP International Ltd.
by Zacks Equity Research
Premium construction company, KBR, Inc.'s (KBR) shares inched up 0.5% to $17.38 per share on Dec 20, after securing two global agreements from BP International Limited.
KBR Continues to Face Macro Challenges: Should you Hold?
by Zacks Equity Research
Over the past six months, KBR, Inc.'s (KBR) shares recorded an average return of 10.5%, underperforming the Zacks categorized Engineering/R&D Services industry average of 14.3%.
4 Construction Picks to Beat Q2 Earnings on Builder Optimism
by Zacks Equity Research
Construction trends are expected to improve further in the second half of the year.
Top Momentum Stocks for the Week - (FLXN) (KBR)
by David Bartosiak
Momentum Stock Strategist David Bartosiak discusses this week's top momentum stocks, Flexion Therapeutics and KBR Inc.